GXP PHARMAID ApS: Financial statements 2022
CVR: 29615861
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 349,682 and a net result of DKK -324,771 compared with DKK -503,961 the year before. That is a decrease of 3.8% compared with the year before. Equity in the 2022 report amounted to DKK 366,516. The solvency ratio was 29.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 349,682
- Profit/Loss
- DKK -324,771
- Equity
- DKK 366,516
- Total Assets
- DKK 1,246,435
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 350 t. | -325 t. | 367 t. | 1 |
| 2021 | - | 363 t. | -504 t. | 691 t. | 2 |
| 2020 | - | 2.8 mio. | 960 t. | 1.7 mio. | 3 |
| 2019 | - | 763 t. | -169 t. | 735 t. | 1 |
| 2018 | - | 1.1 mio. | 217 t. | 904 t. | 1 |
Official annual report
Keep an eye on GXP PHARMAID ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GXP PHARMAID ApS has published its annual report for 2021. Gross profit came to DKK 363,324, and the net result was DKK -503,961.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Q-VIGILANCE ApS. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.